Clinical Trials Browser

Phase 1/2 × OTHER × Aromatase Inhibitors × Clear all

NCT01484041 2018-02-09

Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer

Phase 1/2 Terminated

12 enrolled 7 charts

Breast Neoplasms